Why can mRNA vaccines be developed faster than many other vaccine types?
mRNA vaccines can be developed more rapidly than traditional vaccines primarily because they rely on synthetic technologies that eliminate the need to grow live viruses or other biological components in a laboratory.12
Traditional vaccine development often requires complex and time-consuming processes to cultivate weakened or inactivated pathogens. In contrast, mRNA vaccines use synthetic messenger RNA to provide cells with instructions to produce specific, harmless protein fragments of a pathogen, which then train the immune system to recognize the disease.13
This approach offers two key advantages for speed:
* Efficiency: By bypassing the need for biological cultivation, the manufacturing process can be standardized and scaled up quickly.12
* Adaptability: The mRNA sequence can be rapidly modified to address new viral variants or entirely different pathogens, making the platform highly flexible for emerging health threats.13